Redesigning allogeneic bone marrow transplantation as immunotherapy for solid cancers KU Leuven
Although only recently cancer immunotherapy has received great attention with the development of checkpoint inhibitors, cancer immunotherapy has been around for more than 3 decades. In fact, allogeneic bone marrow transplantation (alloBMT) was the first form of cancer immunotherapy as its anti-tumor effects are strictly dependent on immune-mediated anti-tumor reactivity mediated by immune cells contained in the transplanted graft or derived ...